0001437749-22-000656.txt : 20220110 0001437749-22-000656.hdr.sgml : 20220110 20220110150807 ACCESSION NUMBER: 0001437749-22-000656 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220110 DATE AS OF CHANGE: 20220110 EFFECTIVENESS DATE: 20220110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 76Bio, Inc. CENTRAL INDEX KEY: 0001903465 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-428624 FILM NUMBER: 22521065 BUSINESS ADDRESS: STREET 1: 689 FIFTH AVENUE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-871-7920 MAIL ADDRESS: STREET 1: 689 FIFTH AVENUE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 D 1 primary_doc.xml X0708 D LIVE 0001903465 76Bio, Inc. 689 Fifth Avenue 12th Floor New York NY NEW YORK 10022 212-871-7920 DELAWARE TRC 2001, Inc. None Corporation true 2020 Christopher M. Wilfong 689 Fifth Avenue 12th Floor New York NY NEW YORK 10022 Executive Officer Director Promoter David Tanen 689 Fifth Avenue 12th Floor New York NY NEW YORK 10022 Executive Officer Director Promoter Angela Koehler 689 Fifth Avenue 12th Floor New York NY NEW YORK 10022 Director Biotechnology Decline to Disclose 06b false 2021-12-22 false true false 0 10005244 10005244 0 Total Offering Amount and Total Amount Sold includes $2,343,175.34, which represents the conversion of convertible promissory notes and accrued interest. false 44 0 0 0 false 76Bio, Inc. /s/ David Tanen David Tanen Secretary 2022-01-07